G-Vanc Indications/Uses

Vancomycin is indicated in the treatment of severe, potentially life-threatening Staphylococcal infections in patients who can not receive penicillins or cephalosporins or who have failed to respond to them.
Vancomycin is indicated for prophylaxis of bacterial endocarditis in penicillin-allergic patients with prosthetic heart valves or congenital, rheumatic, or other acquired valvular heart disease who are undergoing dental procedures or surgical procedures of the upper respiratory tract.
Vancomycin is indicated in the treatment of bone and joint infections (including osteomyelitis), pneumonia, septicemia, skin and soft tissue infections caused by susceptible strains of Staphylococcus species (including methicillin-resistant strains), endocarditis caused by Staphylococcus species (including methicillin-resistant strains).
Vancomycin is also indicated as a primary agent, alone or concurrently with an aminoglycoside or rifampin, in endocarditis caused by Corynebacterium species (diphtheroids) (including penicillin-resistant and cephalosporin-resistant strains) in penicillin-allergic patients, and as a secondary agent in endocarditis caused by Streptococcus viridians or Streptococcus bovis.